Skip to main content
Premium Trial:

Request an Annual Quote

Febit Biotech

Premium
Febit Biotech this week launched its 3’-Inversed Synthesis Set for reverse synthesis of DNA oligonucleotides on arrays used with its Geniom system.
 
Using the 3’-Inversed Synthesis Set customers can now directly apply enzymes to Geniom arrays. The company added that oligonucleotides with a free 3´end are accessible to nucleic acid polymerases and could serve as primers for polymerase-based assays.
 
“The fields of application [for this chip] are diverse, and include all major markets for RT-qPCR” including environmental testing, biodefense, and molecular diagnostics, a Febit spokesperson told BioArray News this week.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.